Source of information
The following is a list of referencs that were used to inform the IBSclinic content:
American Psychiatric Association. (2017a). What Are Anxiety Disorders? Retrieved from https://www.psychiatry.org/patients-families/anxiety-disorders/what-are-anxiety-disorders
American Psychiatric Association. (2017b). What is Depression? Retrieved from https://www.psychiatry.org/patients-families/depression/what-is-depression
Ballou, S., Bedell, A., & Keefer, L. (2015). Psychosocial impact of irritable bowel syndrome: A brief review. World journal of gastrointestinal pathophysiology, 6(4), 120.
BetterHealthChannel. (2018). Irritable bowel syndrome (IBS). Retrieved from https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/irritable-bowel-syndrome-ibs
Beyond Blue. (n.d.). Anxiety. Retrieved from https://www.beyondblue.org.au/the-facts/anxiety/signs-and-symptoms
Bharadwaj, S., Barber, M. D., Graff, L. A., & Shen, B. (2015). Symptomatology of irritable bowel syndrome and inflammatory bowel disease during the menstrual cycle. Gastroenterology report, 3(3), 185-193.
Burgell, R. E., & Skardoon, G. (2017). The role of biofeedback in functional gastrointestinal disorders. In Functional Gastrointestinal Disorders (pp. 80-91): Routledge.
Canavan, C., West, J., & Card, T. (2014). The epidemiology of irritable bowel syndrome. Clinical epidemiology, 6, 71.
Drossman, D. A., Chang, L., Bellamy, N., Gallo-Torres, H., Lembo, A., Mearin, F., . . . Whorwell, P. (2011). Severity in irritable bowel syndrome: a Rome Foundation Working Team report. The American journal of gastroenterology, 106(10), 1749.
Farzaei, M. H., Bahramsoltani, R., Abdollahi, M., & Rahimi, R. (2016). The role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatments. Journal of neurogastroenterology and motility, 22(4), 558.
Fass, R., Fullerton, S., Naliboff, B., Hirsh, T., & Mayer, E. (1998). Sexual dysfunction in patients with irritable bowel syndrome and non-ulcer dyspepsia. Digestion, 59(1), 79-85.
Fond, G., Loundou, A., Hamdani, N., Boukouaci, W., Dargel, A., Oliveira, J., . . . Boyer, L. (2014). Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. European archives of psychiatry and clinical neuroscience, 264(8), 651-660.
Gastrointestinal Society. (2019). Pelvic Floor Dysfunction. Retrieved from https://badgut.org/information-centre/a-z-digestive-topics/pelvic-floor-dysfunction/
International Foundation for Gastrointestinal Disorders. (2016a). Bloating in IBS. Retrieved from https://www.aboutibs.org/signs-and-symptoms-main/bloating-in-ibs-2.html
International Foundation for Gastrointestinal Disorders. (2016b). Diagnosis of IBS. Retrieved from https://www.aboutibs.org/diagnosis-of-ibs.html
International Foundation for Gastrointestinal Disorders. (2016c). Gynecological Aspects of Irritable Bowel Syndrome. Retrieved from https://www.aboutibs.org/gynecological-aspects-of-irritable-bowel-syndrome.html
International Foundation for Gastrointestinal Disorders. (2016d). Post Infectious IBS. Retrieved from https://www.aboutibs.org/what-is-ibs-sidenav/post-infectious-ibs.html
International Foundation for Gastrointestinal Disorders. (2016e). Pregnancy and Irritable Bowel Syndrome. Retrieved from https://www.aboutibs.org/pregnancy-and-ibs.html
International Foundation for Gastrointestinal Disorders. (2016f). Stress and IBS. Retrieved from https://www.aboutibs.org/what-is-ibs-sidenav/stress-and-ibs.html
International Foundation for Gastrointestinal Disorders. (2017a). Gut Bacteria and IBS. Retrieved from https://www.aboutibs.org/gut-bacteria-and-ibs.html
International Foundation for Gastrointestinal Disorders. (2017b). Pain in IBS. Retrieved from https://www.aboutibs.org/signs-and-symptoms-main/pain-in-ibs-2.html
Khan, S., & Chang, L. (2010). Diagnosis and management of IBS. Nature reviews Gastroenterology & hepatology, 7(10), 565.
Lacy, B., & Patel, N. (2017). Rome criteria and a diagnostic approach to irritable bowel syndrome. Journal of clinical medicine, 6(11), 99.
Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016). Bowel disorders. Gastroenterology, 150(6), 1393-1407. e1395.
Leahy, A., & Epstein, O. (2001). Non-pharmacological treatments in the irritable bowel syndrome. World journal of gastroenterology, 7(3), 313.
Mayo Clinic. (2018a). Anxiety disorders. Retrieved from https://www.mayoclinic.org/diseases-conditions/anxiety/symptoms-causes/syc-20350961
Mayo Clinic. (2018b). Irritable bowel syndrome. Retrieved from https://www.mayoclinic.org/diseases-conditions/irritable-bowel-syndrome/symptoms-causes/syc-20360016
Mayo Clinic. (2019). Food allergy vs. food intolerance: What’s the difference? Retrieved from https://www.mayoclinic.org/diseases-conditions/food-allergy/expert-answers/food-allergy/faq-20058538
Monash FODMAP. (2019a). FODMAPs and Irritable Bowel Syndrome. Retrieved from https://www.monashfodmap.com/about-fodmap-and-ibs/
Monash FODMAP. (2019b). Starting the FODMAP diet. Retrieved from https://www.monashfodmap.com/ibs-central/i-have-ibs/starting-the-low-fodmap-diet/
National Institute of Diabetes and Digestive and Kidney Diseases. (2017). Diagnosis of Irritable Bowel Syndrome. Retrieved from https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/diagnosis
NHS. (2016). Food intolerance. Retrieved from https://www.nhs.uk/conditions/food-intolerance/
NPS MedicineWise. (2012). Prucalopride. Retrieved from https://www.nps.org.au/australian-prescriber/articles/prucalopride
Occhipinti, K., & Smith, J. W. (2012). Irritable bowel syndrome: a review and update. Clinics in colon and rectal surgery, 25(01), 046-052.
Omer, A., & Quigley, E. M. (2017). An update on prucalopride in the treatment of chronic constipation. Therapeutic advances in gastroenterology, 10(11), 877-887.
Ottillinger, B., Storr, M., Malfertheiner, P., & Allescher, H.-D. (2013). STW 5 (Iberogast®)—a safe and effective standard in the treatment of functional gastrointestinal disorders. Wiener Medizinische Wochenschrift, 163(3-4), 65-72.
Qin, H.-Y., Cheng, C.-W., Tang, X.-D., & Bian, Z.-X. (2014). Impact of psychological stress on irritable bowel syndrome. World Journal of Gastroenterology: WJG, 20(39), 14126.
Quigley, E. M. (2018). The genetics of irritable bowel syndrome—some progress at last? Digestive Medicine Research, 1.
Rayner, C. K. (2017). Functional gastrointestinal disorders and the brain-gut axis. In Functional Gastrointestinal Disorders (pp. 22-30): Routledge.
Saha, L. (2014). Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World Journal of Gastroenterology: WJG, 20(22), 6759.
Saito, Y., Zimmerman, J., s. harmsen, w., De Andrade, M., Locke Iii, G., Petersen, G. M., & Talley, N. (2008). Irritable bowel syndrome aggregates strongly in families: a family‐based case‐control study. Neurogastroenterology & Motility, 20(7), 790-797.
Saito, Y. A. (2011). The role of genetics in IBS. Gastroenterology Clinics, 40(1), 45-67.
Shen, Y.-H. A., & Nahas, R. (2009). Complementary and alternative medicine for treatment of irritable bowel syndrome. Canadian Family Physician, 55(2), 143-148.
Swagerty, D. L., Walling, A. D., & Klein, R. M. (2002). Lactose intolerance. American family physician, 65(9), 1845-1860.
Talley, N. J. (2003). Evaluation of drug treatment in irritable bowel syndrome. British journal of clinical pharmacology, 56(4), 362-369.
Videlock, E. J., & Chang, L. (2017). Stress, distress and functional gastrointestinal disorders. In Functional Gastrointestinal Disorders (pp. 12-21): Routledge.
Wilkins, T., Pepitone, C., Alex, B., & Schade, R. R. (2012). Diagnosis and management of IBS in adults. American family physician, 86(5), 419.